SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001047469-14-004855
Filing Date
2014-05-12
Accepted
2014-05-12 16:34:41
Documents
5

Document Format Files

Seq Description Document Type Size
1 S-1 a2220091zs-1.htm S-1 1114231
2 EX-23.1 a2220091zex-23_1.htm EX-23.1 2443
3 G346402.JPG g346402.jpg GRAPHIC 10962
4 G930584.JPG g930584.jpg GRAPHIC 44088
5 G1013783.JPG g1013783.jpg GRAPHIC 14095
  Complete submission text file 0001047469-14-004855.txt   1213358
Mailing Address 420 LEXINGTON AVENUE SUITE 2012 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE SUITE 2012 NEW YORK NY 10170 212-297-0020
ContraVir Pharmaceuticals, Inc. (Filer) CIK: 0001583771 (see all company filings)

IRS No.: 462783806 | State of Incorp.: DE | Fiscal Year End: 0630
Type: S-1 | Act: 33 | File No.: 333-195884 | Film No.: 14833818
SIC: 2834 Pharmaceutical Preparations